Alzamend Neuro, Inc.

ALZN·NasdaqCM
Compare
1.3100−0.0301 (−2.25%)today
At close: Oct 12, 4:00 PM EDT · May be delayed up to 15 min · USD

Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.

Key statistics

Previous close1.3401
Open1.4287
Day range1.31001.4287
52-week range0.84002.6800
Off day high−8.31%
Off 52-week high−51.12%
Volume17.03K
Avg. volume (3M)86.88K
Market cap6.32M
EPS (TTM)-2.30
Forward P/E-1.51
P/E ratio (TTM)—
Dividend yield—
Beta (5Y)—
Shares outstanding4.83M
Short interest—
Earnings dateJul 28, 2025 (est.)
Analyst target—
Profit margin—

Against its peers

Compare in full ›
ALZN NRSN ADXN NEUP SILO ALEC
Market cap 6.32M 6.60M 5.33M 17.97M 3.06M 232.25M
P/E (TTM) — — — — — —
Forward P/E -1.5 -0.5 -60.8 -1.3 -2.1 -2.8
Price/book 1.1 -3.6 1.4 0.6 0.3 -23.4
Dividend yield — — — — — —
1-year change −41.52% −85.00% −64.32% −79.90% −84.39% −30.43%
Today −2.25% −4.92% −5.55% −1.19% +1.36% 0.00%

The closest companies by business and industry (Biotechnology). Prices may be delayed up to 15 min.

Latest news

All ALZN news ›

No recent coverage in the 4Search index.

From articles in the 4Search news index.

Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4Search index. Terms of use.